Application of droplet digital PCR for the detection of vector copy number in clinical CAR/TCR T cell products
Abstract Background Genetically engineered T cells have become an important therapy for B-cell malignancies. Measuring the efficiency of vector integration into the T cell genome is important for assessing the potency and safety of these cancer immunotherapies. Methods A digital droplet polymerase c...
Main Authors: | Alex Lu, Hui Liu, Rongye Shi, Yihua Cai, Jinxia Ma, Lipei Shao, Victor Rong, Nikolaos Gkitsas, Hong Lei, Steven L. Highfill, Sandhya Panch, David F. Stroncek, Ping Jin |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-05-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12967-020-02358-0 |
Similar Items
-
Engineering Strategies to Enhance TCR-Based Adoptive T Cell Therapy
by: Jan A. Rath, et al.
Published: (2020-06-01) -
Adoptive Immunotherapy beyond CAR T-Cells
by: Aleksei Titov, et al.
Published: (2021-02-01) -
TCR-Like CAR-T Cells Targeting MHC-Bound Minor Histocompatibility Antigens
by: Yoshiki Akatsuka
Published: (2020-02-01) -
The Quest for the Best: How TCR Affinity, Avidity, and Functional Avidity Affect TCR-Engineered T-Cell Antitumor Responses
by: Diana Campillo-Davo, et al.
Published: (2020-07-01) -
Genetically Engineered T-Cells for Malignant Glioma: Overcoming the Barriers to Effective Immunotherapy
by: Pavlina Chuntova, et al.
Published: (2019-01-01)